1,271
Participants
Start Date
August 16, 2024
Primary Completion Date
July 18, 2025
Study Completion Date
July 18, 2025
No Drug
This is an non-interventional, observational study. No drug was administered during this study.
China-Japan Friendship Hospital, Beijing
Beijing Hospital, Beijing
Beijing Cancer Hospital, Beijing
Liaoning Cancer Hospital & Institute, Shenyang
The First Affiliated Hospital of Dalian Medical University, Dalian
Cancer Hospital of Shandong First Medical University (Shandong Cancer Institute, Shandong Cancer Hospital), Jinan
Zhejiang Provincial People's Hospital, Hangzhou
The First Affiliated Hospital of Fujian Medical University, Fuzhou
Tongji Hospital Tongji Medical College of Hust, Wuhan
Sun Yat-Sen University Cancer Center, Guangzhou
Lead Sponsor
Collaborators (1)
Daiichi Sankyo Co., Ltd.
INDUSTRY
Daiichi Sankyo
INDUSTRY